Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection.

Maekura R, Kitada S, Osada-Oka M, Tateishi Y, Ozeki Y, Fujicawa T, Miki M, Jyunnko O, Mori M, Matsumoto S.

Microbiol Immunol. 2019 Mar;63(3-4):130-138. doi: 10.1111/1348-0421.12674. Epub 2019 Apr 9.

PMID:
30851131
2.

Human airway trypsin-like protease enhances interleukin-8 synthesis in bronchial epithelial cells by activating protease-activated receptor 2.

Miki M, Yasuoka S, Tsutsumi R, Nakamura Y, Hajime M, Takeuchi Y, Miki K, Kitada S, Maekura R.

Arch Biochem Biophys. 2019 Mar 30;664:167-173. doi: 10.1016/j.abb.2019.01.019. Epub 2019 Jan 21.

PMID:
30677406
3.

Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.

Ohara Y, Ozeki Y, Tateishi Y, Mashima T, Arisaka F, Tsunaka Y, Fujiwara Y, Nishiyama A, Yoshida Y, Kitadokoro K, Kobayashi H, Kaneko Y, Nakagawa I, Maekura R, Yamamoto S, Katahira M, Matsumoto S.

PLoS One. 2018 Oct 25;13(10):e0204160. doi: 10.1371/journal.pone.0204160. eCollection 2018.

4.

Dyspnea and the Varying Pathophysiologic Manifestations of Chronic Obstructive Pulmonary Disease Evaluated by Cardiopulmonary Exercise Testing With Arterial Blood Analysis.

Kagawa H, Miki K, Kitada S, Miki M, Yoshimura K, Oshitani Y, Nishida K, Sawa N, Tsujino K, Maekura R.

Front Physiol. 2018 Oct 2;9:1293. doi: 10.3389/fphys.2018.01293. eCollection 2018.

5.

Exercise tolerance and balance of inspiratory-to-expiratory muscle strength in relation to breathing timing in patients with chronic obstructive pulmonary disease.

Miki K, Tsujino K, Edahiro R, Kitada S, Miki M, Yoshimura K, Kagawa H, Oshitani Y, Ohara Y, Hosono Y, Kurebe H, Maekura R.

J Breath Res. 2018 Mar 28;12(3):036008. doi: 10.1088/1752-7163/aaa6db.

PMID:
29321341
6.

Comparison of Different Disease-Specific Health-Related Quality of Life Measurements in Patients with Long-Term Noninvasive Ventilation.

Oga T, Taniguchi H, Kita H, Tsuboi T, Tomii K, Ando M, Kojima E, Tomioka H, Taguchi Y, Kaji Y, Maekura R, Hiraga T, Sakai N, Kimura T, Mishima M, Windisch W, Chin K.

Can Respir J. 2017;2017:8295079. doi: 10.1155/2017/8295079. Epub 2017 May 15.

7.

Pulmonary rehabilitation for COPD improves exercise time rather than exercise tolerance: effects and mechanisms.

Miki K, Maekura R, Kitada S, Miki M, Yoshimura K, Yamamoto H, Kawabe T, Kagawa H, Oshitani Y, Satomi A, Nishida K, Sawa N, Inoue K.

Int J Chron Obstruct Pulmon Dis. 2017 Apr 3;12:1061-1070. doi: 10.2147/COPD.S131061. eCollection 2017.

8.

Validation of the Japanese Severe Respiratory Insufficiency Questionnaire in hypercapnic patients with noninvasive ventilation.

Oga T, Taniguchi H, Kita H, Tsuboi T, Tomii K, Ando M, Kojima E, Tomioka H, Taguchi Y, Kaji Y, Maekura R, Hiraga T, Sakai N, Kimura T, Mishima M, Windisch W, Chin K.

Respir Investig. 2017 Mar;55(2):166-172. doi: 10.1016/j.resinv.2016.12.003. Epub 2017 Feb 6.

PMID:
28274533
9.

Levels of Antibody against Glycopeptidolipid Core as a Marker for Monitoring Treatment Response in Mycobacterium avium Complex Pulmonary Disease: a Prospective Cohort Study.

Kitada S, Maekura R, Yoshimura K, Miki K, Miki M, Oshitani Y, Nishida K, Sawa N, Mori M, Kobayashi K.

J Clin Microbiol. 2017 Mar;55(3):884-892. doi: 10.1128/JCM.02010-16. Epub 2016 Dec 28.

10.

Solitary pulmonary nodules due to non-tuberculous mycobacteriosis among 28 resected cases.

Ose N, Maeda H, Takeuchi Y, Susaki Y, Kobori Y, Taniguchi S, Maekura R.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1125-9. doi: 10.5588/ijtld.15.0819.

PMID:
27393550
11.

[Nutrition management for COPD].

Miki K, Maekura R.

Nihon Rinsho. 2016 May;74(5):801-6. Review. Japanese.

PMID:
27254950
12.

[THE GENETIC EXAMINATION OF BRONCHIAL LAVAGE ENABLES THE PROMPT DIAGNOSIS OF PULMONARY MYCOBACTERIUM KANSASII--A CASE REPORT].

Mori M, Ageshio F, Kagawa H, Oshitani Y, Fujikawa T, Saito H, Sako H, Yano Y, Kitada S, Maekura R.

Kekkaku. 2015 Aug;90(8):619-23. Japanese.

PMID:
26665518
13.

Analysis of the relationship between health status and mortality in hypercapnic patients with noninvasive ventilation.

Oga T, Taniguchi H, Kita H, Tsuboi T, Tomii K, Ando M, Kojima E, Tomioka H, Taguchi Y, Kaji Y, Maekura R, Hiraga T, Sakai N, Kimura T, Mishima M, Chin K.

Clin Respir J. 2017 Nov;11(6):772-780. doi: 10.1111/crj.12415. Epub 2015 Dec 28.

PMID:
26605994
14.

Exogenous lipoid pneumonia caused by repeated sesame oil pulling: a report of two cases.

Kuroyama M, Kagawa H, Kitada S, Maekura R, Mori M, Hirano H.

BMC Pulm Med. 2015 Oct 30;15:135. doi: 10.1186/s12890-015-0134-8.

15.

Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.

Maekura R, Hiraga T, Miki K, Kitada S, Miki M, Yoshimura K, Yamamoto H, Kawabe T, Mori M.

Int J Chron Obstruct Pulmon Dis. 2015 Sep 3;10:1787-800. doi: 10.2147/COPD.S86455. eCollection 2015.

16.

Randomized, dose-finding trial of ghrelin treatment for chronic respiratory failure.

Miki K, Maekura R, Nakazato M, Matsumoto N, Kitada S, Miki M, Yoshimura K, Mori M, Kangawa K.

Clin Respir J. 2017 Jul;11(4):496-505. doi: 10.1111/crj.12364. Epub 2015 Sep 10.

PMID:
26260705
17.

Effects of ghrelin treatment on exertional dyspnea in COPD: an exploratory analysis.

Miki K, Maekura R, Nagaya N, Miki M, Kitada S, Yoshimura K, Mori M, Kangawa K.

J Physiol Sci. 2015 May;65(3):277-84. doi: 10.1007/s12576-015-0366-7. Epub 2015 Feb 28.

PMID:
25724656
18.

Ghrelin administration for chronic respiratory failure: a randomized dose-comparison trial.

Matsumoto N, Miki K, Tsubouchi H, Sakamoto A, Arimura Y, Yanagi S, Iiboshi H, Yoshida M, Souma R, Ishimoto H, Yamamoto Y, Yatera K, Yoshikawa M, Sagara H, Iwanaga T, Mukae H, Maekura R, Kimura H, Nakazato M, Kangawa K.

Lung. 2015 Apr;193(2):239-47. doi: 10.1007/s00408-015-9685-y. Epub 2015 Jan 30.

PMID:
25634352
19.

Validation of a commercial serodiagnostic kit for diagnosing pulmonary Mycobacterium avium complex disease.

Kitada S, Yoshimura K, Miki K, Miki M, Hashimoto H, Matsui H, Kuroyama M, Ageshio F, Kagawa H, Mori M, Maekura R, Kobayashi K.

Int J Tuberc Lung Dis. 2015 Jan;19(1):97-103. doi: 10.5588/ijtld.14.0564.

PMID:
25519798
20.

Direct detection of Mycobacterium avium in environmental water and scale samples by loop-mediated isothermal amplification.

Nishiuchi Y, Tamaru A, Suzuki Y, Kitada S, Maekura R, Tateishi Y, Niki M, Ogura H, Matsumoto S.

J Water Health. 2014 Jun;12(2):211-9. doi: 10.2166/wh.2013.007.

PMID:
24937215
21.

Identification of three exercise-induced mortality risk factors in patients with COPD.

Yoshimura K, Maekura R, Hiraga T, Miki K, Kitada S, Miki M, Tateishi Y, Mori M.

COPD. 2014 Dec;11(6):615-26. doi: 10.3109/15412555.2014.898038. Epub 2014 Jun 10.

PMID:
24914923
22.

Differences in physiological response to exercise in patients with different COPD severity.

Maekura R, Hiraga T, Miki K, Kitada S, Yoshimura K, Miki M, Tateishi Y.

Respir Care. 2014 Feb;59(2):252-62. doi: 10.4187/respcare.02201. Epub 2013 Jul 2.

23.

Effects of ghrelin treatment on exercise capacity in underweight COPD patients: a substudy of a multicenter, randomized, double-blind, placebo-controlled trial of ghrelin treatment.

Miki K, Maekura R, Nagaya N, Kitada S, Miki M, Yoshimura K, Tateishi Y, Motone M, Hiraga T, Mori M, Kangawa K.

BMC Pulm Med. 2013 Jun 10;13:37. doi: 10.1186/1471-2466-13-37.

24.

Exertional acidotic responses in idiopathic pulmonary fibrosis: the mechanisms of exertional dyspnea.

Miki K, Maekura R, Miki M, Kitada S, Yoshimura K, Tateishi Y, Mori M.

Respir Physiol Neurobiol. 2013 Feb 1;185(3):653-8. doi: 10.1016/j.resp.2012.11.008. Epub 2012 Dec 12.

PMID:
23246672
25.

Antigen 85A and mycobacterial DNA-binding protein 1 are targets of immunoglobulin G in individuals with past tuberculosis.

Osada-Oka M, Tateishi Y, Hirayama Y, Ozeki Y, Niki M, Kitada S, Maekura R, Tsujimura K, Koide Y, Ohara N, Yamamoto T, Kobayashi K, Matsumoto S.

Microbiol Immunol. 2013 Jan;57(1):30-7. doi: 10.1111/j.1348-0421.2012.12005.x.

26.

Whole-genome sequence of the hypervirulent clinical strain Mycobacterium intracellulare M.i.198.

Tateishi Y, Kitada S, Miki K, Maekura R, Ogura Y, Ozeki Y, Nishiuchi Y, Niki M, Hayashi T, Hirata K, Kobayashi K, Matsumoto S.

J Bacteriol. 2012 Nov;194(22):6336. doi: 10.1128/JB.01439-12.

27.

Dominant incidence of multidrug and extensively drug-resistant specific Mycobacterium tuberculosis clones in Osaka Prefecture, Japan.

Tamaru A, Nakajima C, Wada T, Wang Y, Inoue M, Kawahara R, Maekura R, Ozeki Y, Ogura H, Kobayashi K, Suzuki Y, Matsumoto S.

PLoS One. 2012;7(8):e42505. doi: 10.1371/journal.pone.0042505. Epub 2012 Aug 31.

28.

Pulmonary disease caused by rapidly growing mycobacteria: a retrospective study of 44 cases in Japan.

Yano Y, Kitada S, Mori M, Kagami S, Taguri T, Uenami T, Namba Y, Yoneda T, Yokota S, Maekura R.

Respiration. 2013;85(4):305-11. doi: 10.1159/000339631. Epub 2012 Aug 11.

29.

Effects of inhaled tiotropium on left ventricular diastolic function in chronic obstructive pulmonary disease patients after pulmonary resection.

Nojiri T, Yamamoto K, Maeda H, Takeuchi Y, Funakoshi Y, Maekura R, Okumura M.

Ann Thorac Cardiovasc Surg. 2012;18(3):206-11.

30.

Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients.

Yoshimura K, Maekura R, Hiraga T, Kitada S, Miki K, Miki M, Tateishi Y.

Int J Chron Obstruct Pulmon Dis. 2012;7:109-17. doi: 10.2147/COPD.S28677. Epub 2012 May 2.

31.

Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial.

Miki K, Maekura R, Nagaya N, Nakazato M, Kimura H, Murakami S, Ohnishi S, Hiraga T, Miki M, Kitada S, Yoshimura K, Tateishi Y, Arimura Y, Matsumoto N, Yoshikawa M, Yamahara K, Kangawa K.

PLoS One. 2012;7(5):e35708. doi: 10.1371/journal.pone.0035708. Epub 2012 May 1.

32.

Long-term radiographic outcome of nodular bronchiectatic Mycobacterium avium complex pulmonary disease.

Kitada S, Uenami T, Yoshimura K, Tateishi Y, Miki K, Miki M, Hashimoto H, Fujikawa T, Mori M, Matsuura K, Kuroyama M, Maekura R.

Int J Tuberc Lung Dis. 2012 May;16(5):660-4. doi: 10.5588/ijtld.11.0534. Epub 2012 Mar 7.

PMID:
22410245
33.

Efficacy of low-dose landiolol, an ultrashort-acting β-blocker, on postoperative atrial fibrillation in patients undergoing pulmonary resection for lung cancer.

Nojiri T, Yamamoto K, Maeda H, Takeuchi Y, Funakoshi Y, Maekura R, Okumura M.

Gen Thorac Cardiovasc Surg. 2011 Dec;59(12):799-805. doi: 10.1007/s11748-011-0841-x. Epub 2011 Dec 16.

PMID:
22173677
34.

[Smoking cessation].

Mori M, Maekura R.

Nihon Rinsho. 2011 Oct;69(10):1831-5. Japanese.

PMID:
22073582
35.

Effects of oxygen on exertional dyspnoea and exercise performance in patients with chronic obstructive pulmonary disease.

Miki K, Maekura R, Hiraga T, Kitada S, Miki M, Yoshimura K, Tateishi Y.

Respirology. 2012 Jan;17(1):149-54. doi: 10.1111/j.1440-1843.2011.02086.x.

PMID:
22008208
36.

[Susceptibility to rifabutin and novel fluoroquinolones in Mycobacterium avium complex isolates from patients with sputum culture-positive pulmonary disease who are undergoing standard chemotherapy].

Tateishi Y, Motone M, Yoshimura K, Miki M, Miki K, Kitada S, Hashimoto H, Hiraga T, Maekura R.

Nihon Kokyuki Gakkai Zasshi. 2010 Nov;48(11):797-802. Japanese.

PMID:
21141056
37.

A case of acute and severe thrombocytopenia due to readministration of rifampicin.

Mori M, Izawa K, Fujikawa T, Uenami T, Sugano T, Kagami S, Namba Y, Yano Y, Yoneda T, Kitada S, Kimura H, Yamaguchi T, Yokota S, Maekura R.

J Infect Chemother. 2011 Apr;17(2):288-90. doi: 10.1007/s10156-010-0117-x. Epub 2010 Sep 9.

PMID:
20827562
38.

Predictive value of preoperative tissue Doppler echocardiographic analysis for postoperative atrial fibrillation after pulmonary resection for lung cancer.

Nojiri T, Maeda H, Takeuchi Y, Funakoshi Y, Maekura R, Yamamoto K, Okumura M.

J Thorac Cardiovasc Surg. 2010 Oct;140(4):764-8. doi: 10.1016/j.jtcvs.2009.11.073. Epub 2010 Aug 9.

39.

Serodiagnosis of pulmonary disease due to Mycobacterium avium complex proven by bronchial wash culture.

Kitada S, Kobayashi K, Nishiuchi Y, Fushitani K, Yoshimura K, Tateishi Y, Miki K, Miki M, Hashimoto H, Motone M, Fujikawa T, Hiraga T, Maekura R.

Chest. 2010 Jul;138(1):236-7. doi: 10.1378/chest.10-0248. No abstract available.

PMID:
20605832
40.

Exertional dyspnea-related acidotic and sympathetic responses in patients with sequelae of pulmonary tuberculosis.

Miki K, Maekura R, Hiraga T, Hashimoto H, Kitada S, Miki M, Yoshimura K, Tateishi Y, Sugano T, Motone M.

J Physiol Sci. 2010 May;60(3):187-93. doi: 10.1007/s12576-009-0083-1. Epub 2010 Jan 20.

PMID:
20087706
41.

Predictive value of B-type natriuretic peptide for postoperative atrial fibrillation following pulmonary resection for lung cancer.

Nojiri T, Maeda H, Takeuchi Y, Funakoshi Y, Kimura T, Maekura R, Yamamoto K, Okumura M.

Eur J Cardiothorac Surg. 2010 Apr;37(4):787-91. doi: 10.1016/j.ejcts.2009.09.043. Epub 2009 Nov 6.

PMID:
19896864
42.

Acidosis and raised norepinephrine levels are associated with exercise dyspnoea in idiopathic pulmonary fibrosis.

Miki K, Maekura R, Hiraga T, Hashimoto H, Kitada S, Miki M, Yoshimura K, Tateishi Y, Fushitani K, Motone M.

Respirology. 2009 Sep;14(7):1020-6. doi: 10.1111/j.1440-1843.2009.01607.x.

PMID:
19740262
43.

Mycobacterium avium complex organisms predominantly colonize in the bathtub inlets of patients' bathrooms.

Nishiuchi Y, Tamura A, Kitada S, Taguri T, Matsumoto S, Tateishi Y, Yoshimura M, Ozeki Y, Matsumura N, Ogura H, Maekura R.

Jpn J Infect Dis. 2009 May;62(3):182-6.

44.

[Clinical research on multi-drug resistant and extensive drug-resistant tuberculosis in Japan].

Toyota E, Kawabe Y, Yotsumoto H, Sakatani M, Tsuyuguchi K, Maekura R, Fujikawa K, Takashima T, Ogawa K, Yoshiyama T, Sugie T.

Kekkaku. 2008 Dec;83(12):773-7. Japanese.

PMID:
19172822
45.

Virulence of Mycobacterium avium complex strains isolated from immunocompetent patients.

Tateishi Y, Hirayama Y, Ozeki Y, Nishiuchi Y, Yoshimura M, Kang J, Shibata A, Hirata K, Kitada S, Maekura R, Ogura H, Kobayashi K, Matsumoto S.

Microb Pathog. 2009 Jan;46(1):6-12. doi: 10.1016/j.micpath.2008.10.007. Epub 2008 Nov 1.

PMID:
19013228
46.

[A case of lung adenocarcinoma effectively treated with sivelestat and corcicosteroid for drug-induced lung disease due to gefitinib].

Mori M, Iwasaki T, Nakazawa Y, Namba Y, Niinaka M, Yano Y, Kitada S, Kimura H, Naka N, Okada T, Nakagawa M, Maekura R, Yokota S.

Nihon Kokyuki Gakkai Zasshi. 2008 Mar;46(3):232-6. Japanese.

PMID:
18409572
47.

Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit.

Kitada S, Kobayashi K, Ichiyama S, Takakura S, Sakatani M, Suzuki K, Takashima T, Nagai T, Sakurabayashi I, Ito M, Maekura R; MAC Serodiagnosis Study Group.

Am J Respir Crit Care Med. 2008 Apr 1;177(7):793-7. Epub 2007 Dec 13.

PMID:
18079497
48.

The degree of exercise hypoxemia reflects pulmonary artery pressure during early exercise in chronic obstructive pulmonary disease patients.

Miki K, Maekura R, Hiraga T, Hirotani A, Hashimoto H, Kitada S, Miki M, Yoshimura K, Naka N, Motone M.

Clin Physiol Funct Imaging. 2008 Jan;28(1):64-9. Epub 2007 Nov 12.

PMID:
18005165
49.

The recovery of Mycobacterium avium-intracellulare complex (MAC) from the residential bathrooms of patients with pulmonary MAC.

Nishiuchi Y, Maekura R, Kitada S, Tamaru A, Taguri T, Kira Y, Hiraga T, Hirotani A, Yoshimura K, Miki M, Ito M.

Clin Infect Dis. 2007 Aug 1;45(3):347-51. Epub 2007 Jun 15.

PMID:
17599313
50.

Evaluation of major membrane protein-II as a tool for serodiagnosis of leprosy.

Maeda Y, Mukai T, Kai M, Fukutomi Y, Nomaguchi H, Abe C, Kobayashi K, Kitada S, Maekura R, Yano I, Ishii N, Mori T, Makino M.

FEMS Microbiol Lett. 2007 Jul;272(2):202-5. Epub 2007 May 22.

Supplemental Content

Loading ...
Support Center